The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A prospective, multi-center study of individualized, pharmacokinetically (PK)-guided dosing of 5-fluorouracil (5-FU) in metastatic colorectal cancer (mCRC) patients treated with weekly or biweekly 5-FU/oxaliplatin containing regimens.
 
Volker Kunzmann
No Relationships to Disclose
 
Karin Link
Honoraria - Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Michael Craig Miller
Employment - Saladax Biomedical
Stock and Other Ownership Interests - Saladax Biomedical
Research Funding - Saladax Biomedical
Travel, Accommodations, Expenses - Saladax Biomedical
 
Stefan Holdenrieder
No Relationships to Disclose
 
Thomas Bertsch
No Relationships to Disclose
 
Lothar Mueller
No Relationships to Disclose
 
Yon-Dschun Ko
No Relationships to Disclose
 
Oliver J. Stoetzer
No Relationships to Disclose
 
Ingo Suttmann
No Relationships to Disclose
 
Jan Braess
No Relationships to Disclose
 
Ulrich Jaehde
No Relationships to Disclose
 
Max Roessler
No Relationships to Disclose
 
Berta Moritz
No Relationships to Disclose
 
Stefanie Kraff
Travel, Accommodations, Expenses - Saladax Biomedical
 
Achim Fritsch
No Relationships to Disclose
 
Salvatore J. Salamone
Employment - Saladax Biomedical
Leadership - Saladax Biomedical
Stock and Other Ownership Interests - Saladax Biomedical
Honoraria - Saladax Biomedical
Patents, Royalties, Other Intellectual Property - Saladax Biomedical
Travel, Accommodations, Expenses - Saladax Biomedical
 
Martin Wilhelm
Research Funding - Hexal (Inst); Novartis (Inst); Pfizer (Inst)